These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37749621)

  • 1. The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia.
    Wils LJ; Poell JB; Peferoen LAN; Evren I; Brouns ER; de Visscher JGAM; van der Meij EH; Brakenhoff RH; Bloemena E
    J Oral Pathol Med; 2023 Nov; 52(10):930-938. PubMed ID: 37749621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
    Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
    Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression].
    Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
    Ned Tijdschr Tandheelkd; 2021 Feb; 128(2):103-111. PubMed ID: 33605260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
    Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
    Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overestimated risk of transformation in oral lichen planus.
    Cai X; Zhang J; Zhang H; Li T
    Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia.
    Brouns ER; Evren I; Wils LJ; Poell JB; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Dis; 2023 Oct; 29(7):2667-2676. PubMed ID: 35765231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
    Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
    Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
    J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
    Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
    BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant Transformation Rate of Non-reactive Oral Hyperkeratoses Suggests an Early Dysplastic Phenotype.
    Stojanov IJ; Woo SB
    Head Neck Pathol; 2022 Jun; 16(2):366-374. PubMed ID: 34255278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal p53 Immunohistochemical Patterns Shed Light on the Aggressiveness of Oral Epithelial Dysplasia.
    Novack R; Zhang L; Hoang LN; Kadhim M; Ng TL; Poh CF; Kevin Ko YC
    Mod Pathol; 2023 Jul; 36(7):100153. PubMed ID: 36906072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
    Schepman KP; van der Meij EH; Smeele LE; van der Waal I
    Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral epithelial dysplasia: Recognition, grading and clinical significance.
    Odell E; Kujan O; Warnakulasuriya S; Sloan P
    Oral Dis; 2021 Nov; 27(8):1947-1976. PubMed ID: 34418233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis.
    Li X; Liu L; Zhang J; Ma M; Sun L; Li X; Zhang H; Wang J; Huang Y; Li T
    Sci China Life Sci; 2021 Sep; 64(9):1379-1391. PubMed ID: 34351567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral leukoplakia, with emphasis on malignant transformation. A follow-up study of 46 patients.
    Hogewind WF; van der Kwast WA; van der Waal I
    J Craniomaxillofac Surg; 1989 Apr; 17(3):128-33. PubMed ID: 2651483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between clinical and histopathological characteristics in oral leukoplakia.
    Evren I; Brouns ER; Poell JB; Wils LJ; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Dis; 2023 Mar; 29(2):696-706. PubMed ID: 34601770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.